A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.
The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) resp...
Egile Nagusiak: | , , , , , , , , , , , |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Mary Ann Liebert, Inc
2016
|
_version_ | 1826302138961100800 |
---|---|
author | Tarunina, M Hernandez, D Kronsteiner-Dobramysl, B Pratt, P Watson, T Hua, P Gullo, F Van der Garde, M Zhang, Y Hook, L Choo, Y Watt, S |
author_facet | Tarunina, M Hernandez, D Kronsteiner-Dobramysl, B Pratt, P Watson, T Hua, P Gullo, F Van der Garde, M Zhang, Y Hook, L Choo, Y Watt, S |
author_sort | Tarunina, M |
collection | OXFORD |
description | The main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) responsible for engraftment. Here, we use combinatorial cell culture technology (CombiCult®) to identify media formulations that promote CD133+ CB HSPC proliferation while maintaining their phenotypic characteristics. We employed second generation CombiCult® screens that use electro-spraying technology to encapsulate CB cells in alginate beads. Our results suggest that, not only the combination, but also the order of addition of individual components has a profound influence on expansion of specific HSPC populations. Top protocols identified by the CombiCult® screen were used to culture human CD133+ CB HSPCs on nanofiber scaffolds and validate the expansion of the phenotypically defined CD34+CD38lo/-CD45RA-CD90+CD49f+ population of hematopoietic stem cells and their differentiation into defined progeny. |
first_indexed | 2024-03-07T05:43:00Z |
format | Journal article |
id | oxford-uuid:e63a9f96-0c48-481f-b5fc-c7ba1fa778e9 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T05:43:00Z |
publishDate | 2016 |
publisher | Mary Ann Liebert, Inc |
record_format | dspace |
spelling | oxford-uuid:e63a9f96-0c48-481f-b5fc-c7ba1fa778e92022-03-27T10:29:49ZA novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e63a9f96-0c48-481f-b5fc-c7ba1fa778e9EnglishSymplectic Elements at OxfordMary Ann Liebert, Inc2016Tarunina, MHernandez, DKronsteiner-Dobramysl, BPratt, PWatson, THua, PGullo, FVan der Garde, MZhang, YHook, LChoo, YWatt, SThe main limitations of hematopoietic cord blood (CB) transplantation, viz. low cell dosage and delayed reconstitution, can be overcome by ex-vivo expansion. CB expansion under conventional culture causes the rapid cell differentiation and depletion of hematopoietic stem/progenitor cells (HSPC) responsible for engraftment. Here, we use combinatorial cell culture technology (CombiCult®) to identify media formulations that promote CD133+ CB HSPC proliferation while maintaining their phenotypic characteristics. We employed second generation CombiCult® screens that use electro-spraying technology to encapsulate CB cells in alginate beads. Our results suggest that, not only the combination, but also the order of addition of individual components has a profound influence on expansion of specific HSPC populations. Top protocols identified by the CombiCult® screen were used to culture human CD133+ CB HSPCs on nanofiber scaffolds and validate the expansion of the phenotypically defined CD34+CD38lo/-CD45RA-CD90+CD49f+ population of hematopoietic stem cells and their differentiation into defined progeny. |
spellingShingle | Tarunina, M Hernandez, D Kronsteiner-Dobramysl, B Pratt, P Watson, T Hua, P Gullo, F Van der Garde, M Zhang, Y Hook, L Choo, Y Watt, S A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title | A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title_full | A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title_fullStr | A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title_full_unstemmed | A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title_short | A novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion. |
title_sort | novel high throughput screening platform reveals an optimised cytokine formulation for human hematopoietic progenitor cell expansion |
work_keys_str_mv | AT taruninam anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT hernandezd anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT kronsteinerdobramyslb anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT prattp anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT watsont anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT huap anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT gullof anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT vandergardem anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT zhangy anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT hookl anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT chooy anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT watts anovelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT taruninam novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT hernandezd novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT kronsteinerdobramyslb novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT prattp novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT watsont novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT huap novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT gullof novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT vandergardem novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT zhangy novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT hookl novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT chooy novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion AT watts novelhighthroughputscreeningplatformrevealsanoptimisedcytokineformulationforhumanhematopoieticprogenitorcellexpansion |